Sigachi Industries
44.82
+2.94(+7.02%)
Market Cap₹1,712.60 Cr
PE Ratio24.74
IndustryHealthcare
Company Performance:
1D+7.02%
1M-19.62%
6M-10.32%
1Y-28.40%
5Y-25.11%
View Company Insightsright
Latest news about Sigachi Industries
Sigachi Industries Shares Plunge 11% Amid Fatal Fire Aftermath 4 days ago
Sigachi Industries' stock price fell nearly 11% on Wednesday, marking the third consecutive day of decline after a fire at its Hyderabad facility claimed 36 lives on June 30. The company is awaiting clearance from the fire department to resume operations and is cooperating with authorities in rescue and restoration efforts. The incident has raised concerns about safety protocols and potential regulatory scrutiny.
Sigachi Industries: Telangana CM Announces Rs 1 Crore Compensation for Plant Explosion Victims 4 days ago
Fire at Sigachi Industries' Hyderabad Plant Halts Operations for 90 Days 5 days ago
Sigachi Industries Secures Approval for New API and Specialty Chemicals Plant Jun 13, 2025
Sigachi Industries Reports Mixed Q4 Results: EBITDA Soars, Net Profit Dips May 30, 2025
More news about Sigachi Industries
07May 25
Sigachi Industries Secures European Certification for Metformin Hydrochloride
Sigachi Industries has obtained a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its Metformin Hydrochloride product. This certification validates the quality and safety standards of the product, potentially enhancing the company's access to the European pharmaceutical market. The CEP is expected to provide Sigachi Industries with a competitive advantage and serve as a quality assurance for European regulators and customers.
28Apr 25
Sigachi Industries' Subsidiary Inks MoU with Respilon for Cutting-Edge Nanofiber Drug Delivery Technology
Sigachi Industries' subsidiary, Sigachi MENA FZCO, has signed an MoU with Czech nanotechnology firm Respilon Group to develop and commercialize drug delivery solutions using NUENEX® nanofiber technology. The partnership focuses on creating Invisible Patch and Powder-based pharmaceutical delivery formats, aiming to revolutionize patient experience and improve therapeutic outcomes through non-invasive, precision drug delivery methods.
17Apr 25
Sigachi Industries Secures Environmental Clearance for Dahej 2 SEZ Facility, Paving Way for Expansion
Sigachi Industries Limited has obtained environmental clearance for a new manufacturing facility in Dahej 2 Special Economic Zone, Gujarat. The facility will have a production capacity of 3,120.00 MT/month, focusing on cellulose and starch-based specialized excipients. This strategic move aims to enhance export growth and global competitiveness in pharmaceutical, nutraceutical, and food-grade applications. The environmental clearance, granted on April 16, 2025, allows the company to proceed with site development and execution.
01Apr 25
Sigachi Industries' Stock Climbs 3.33% Amid Promoter Share Pledge and R&D Investment Plans
Sigachi Industries' stock price increased by 3.33% to ₹36.30 on Tuesday, despite overall weak market conditions. This rise occurred despite a recent share pledge by promoter Dharani Devi Chidambaranatham of 9,10,000 shares (0.23% equity). The company announced plans to invest $1 million in a new R&D center in Hyderabad, potentially boosting investor confidence in its growth strategy.
13Mar 25
Sigachi Industries Partners with Indian Navy for Health Initiative in Visakhapatnam
Sigachi Industries Limited has signed an MoU with INS Kalinga of the Indian Navy to launch an eight-month community fitness program in Visakhapatnam. The 'Vizag Navy Marathon Promo cum Conditioning Programme' will run from March to October 2025, featuring monthly events on the second Sunday. This partnership aims to promote health, wellness, and community engagement in the coastal city.
Sigachi Industries
44.82
+2.94
(+7.02%)
1 Year Returns:-28.40%
Industry Peers
Sun Pharmaceutical
1,676.30
(-0.20%)
Divis Laboratories
6,906.50
(+0.44%)
Cipla
1,513.30
(+0.30%)
Torrent Pharmaceuticals
3,368.00
(+1.02%)
Dr Reddys Laboratories
1,307.40
(+1.25%)
Zydus Life Science
1,001.00
(+0.16%)
Mankind Pharma
2,439.50
(+3.29%)
Lupin
1,980.90
(+1.34%)
Abbott
34,735.00
(-1.93%)
Aurobindo Pharma
1,191.30
(+3.04%)